Bio Rad Laboratories Stock In The News

BIO Stock  USD 300.41  0.04  0.01%   
The tone or emotional content of news articles related to Bio Rad can affect its prices. Positive news sentiment can lead to an increase in demand for Bio Rad's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Bio Rad's news coverage and content from conventional and social sources shows investors' bearish mood towards Bio Rad Laboratories. The specific impact of Bio Rad news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Bio Rad's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Bio Rad headlines in addition to utilizing other, more conventional financial analysis modules. Check out Bio Rad Backtesting and Bio Rad Hype Analysis.

Bio Rad Today Top News and Investor Outlook

Yahoo News
Q4 2023 OncoCyte Corp Earnings Call
https://finance.yahoo.com/news/q4-2023-oncocyte-corp-earnings-024514859.html
 Bullish
Yahoo News
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
https://finance.yahoo.com/news/bio-rad-chief-operating-officer-201500162.html
 Bullish
Yahoo News
Why Is Perrigo (PRGO) Up 19.1% Since Last Earnings Report?
https://finance.yahoo.com/news/why-perrigo-prgo-19-1-153046764.html
 Bullish
Yahoo News
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
https://finance.yahoo.com/news/bio-rad-appoints-roop-k-123000532.html
 Bullish
Yahoo News
Green Thumb Industries Inc. (GTBIF) Soars 11.3%: Is Further Upside Left in the Stock?
https://finance.yahoo.com/news/green-thumb-industries-inc-gtbif-114900494.html
 Bullish
Yahoo News
Bio-Rad (BIO) Suffers due to BioPharma Softness, Stiff Competition
https://finance.yahoo.com/news/bio-rad-bio-suffers-due-122700428.html
 Bullish
Yahoo News
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
https://finance.yahoo.com/news/bio-rad-participate-fireside-chat-213000789.html
 Neutral
Yahoo News
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2023 Earnings Call Transcript
https://finance.yahoo.com/news/bio-rad-laboratories-inc-nyse-152556047.html
 Bullish
Yahoo News
Bio-Rad (BIO) Q4 Earnings Beat, Revenues Miss, Margins Down
https://finance.yahoo.com/news/bio-rad-bio-q4-earnings-142300910.html
 Neutral
Yahoo News
Q4 2023 Bio Rad Laboratories Inc Earnings Call
https://finance.yahoo.com/news/q4-2023-bio-rad-laboratories-130533385.html
 Bullish

Bio Rad Laboratories Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Bio and other traded companies coverage. We help investors stay connected with Bio headlines for the 16th of April 2024 to make an informed investment decision based on correlating the impacts of news items on Bio Stock performance. Please note that trading solely based on the Bio Rad Laboratories hype is not for everyone as timely availability and quick action are needed to avoid losses.
Bio Rad's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Bio Rad Laboratories investors visualize upcoming and past events in order to time the market based on Bio Rad Laboratories noise-free hype analysis.
Bio Rad stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Bio earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Bio Rad that are available to investors today. That information is available publicly through Bio media outlets and privately through word of mouth or via Bio internal channels. However, regardless of the origin, that massive amount of Bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bio Rad news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bio Rad relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bio Rad's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bio Rad alpha.

Bio Largest EPS Surprises

Earnings surprises can significantly impact Bio Rad's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1993-02-12
1992-12-310.070.06-0.0114 
1994-02-09
1993-12-310.090.130.0444 
1993-04-28
1993-03-310.10.140.0440 
1996-05-01
1996-03-310.340.390.0514 
1995-08-02
1995-06-300.220.270.0522 
1998-12-01
1998-09-300.140.08-0.0642 
View All Earnings Estimates

Bio Rad Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Bio Rad Laboratories Stock. Current markets are slightly bearish. About 56% of major world exchanges and indexes are down. See today's market update for more information.
Macroaxis News: globenewswire.com
11th of April 2024
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
at globenewswire.com 
seekingalpha News
10th of April 2024
Bio-Rads chief operating officer Andrew Last to retire
at seekingalpha.com 
benzinga news
3rd of April 2024
Gene Expression Analysis Market is Expected to Reach 6.2 billion MarketsandMarkets
at benzinga.com 
Yahoo News
28th of March 2024
Global Cell Lysis Market Experiences Robust Growth, Expected to Achieve a CAGR of 6.79 per...
at finance.yahoo.com 
prnewswire News
26th of March 2024
MIRUS BIO NAMED A TOP WORKPLACE BY THE WISCONSIN STATE JOURNAL
at prnewswire.com 
Yahoo News
21st of March 2024
Global Covid-19 Diagnostic Market Research 2024 Revised Outlook on Covid-19 Diagnostics in...
at finance.yahoo.com 
prnewswire News
19th of March 2024
PIVOT BIO CELEBRATED FOR SUSTAINABILITY AND INNOVATION
at prnewswire.com 
news
7th of March 2024
Bio-Rad Laboratories, Inc. Shares Purchased by Sei Investments Co.
at thelincolnianonline.com 
businesswire News
22nd of February 2024
Bio-Rad to Participate in Fireside Chat During Citis 2024 Unplugged Medtech and Life Scien...
at businesswire.com 
news
12th of February 2024
Global Epigenetics Market 2024-2030 Market Poised for Unprecedented Growth, Topping 4.41 B...
at kalkinemedia.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bio Rad in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bio Rad's short interest history, or implied volatility extrapolated from Bio Rad options trading.
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:

Complementary Tools for Bio Stock analysis

When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.56)
Earnings Share
(21.81)
Revenue Per Share
91.453
Quarterly Revenue Growth
(0.07)
Return On Assets
0.0177
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.